from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1709/scpA

LFCtreatmentdescriptionclass of inhibitor

-0.111

Amikacinug/mL Amikacintranslation

0.015

Cap5-10ug/mL Capreomycintranslation

-0.153

Rox10-50 ug/mL Roxithromycintranslation

0.477

SM2-5 ug/mL Streptomycintranslation

-0.749

Tet5-10 ug/mL Tetracyclinetranslation

-0.640

Rif0.2-5ug/mL Rifampicintranscription

0.444

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.073

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.926

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.377

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.263

Clofazimine10-13 ug/mL Clofaziminerespiration

0.528

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.227

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-3.016

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.177

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.466

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.241

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.849

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.451

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.153

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.426

KCN5-20 ug/mL Potassium cyaniderespiration

-0.881

NaN30.2-2 mM Sodium aziderespiration

0.584

Nigericin50 uM Nigericinrespiration

0.518

TRC10-150 ug/mL Triclosanrespiration

-2.441

TRZ10-25 ug/mL Thioridazinerespiration

-1.154

Valinomycin0.5-10 uM Valinomycinrespiration

0.891

ZnSO42 mM ZnSO4respiration

0.434

menadione6-10 ug/mL Menadionerespiration

-0.331

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.285

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.363

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.254

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.372

NRP_1Non-replicating persistence stage 1dosRassociated

0.578

Amp0.2mg/mL AmpicillincellWall

0.172

Cephalexin20-100 ug/mL CephalexincellWall

0.891

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.095

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.504

EMB10-20 ug/mL EthambutolcellWall

0.656

Eta12-40 ug/mL EthionamidecellWall

1.025

INH0.2-0.4 ug/mL IsoniazidcellWall

0.027

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.473

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.303

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.356

BZA0.12 mg/mL BenzamidearomaticAmides

-0.376

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.324

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.856

H2O24 mM hydrogen peroxideDNAdamaging

-0.052

Levo10 ug/mL LevofloxacinDNAdamaging

-0.006

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.087

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.045

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.099

UVUV-irradiationDNAdamaging

-2.212

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.094

Antimycin12.5-50 ug/mL Antimycin A?

0.182

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.044

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.213

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.281

PA8240.2-2 ug/mL PA-824?

0.590

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.473

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.311

Verapamil50 uM Verapamil?

-0.421

mercaptoethanol2 mM 2-Mercaptoethanol?

0.739

methoxatin10-20 ug/mL Methoxatin?